top of page
All posts.
N-LIfT cell therapy shows complete and superior cell killing in solid tumour organoid
London, 6th March 2022 – LIfT BioSciences,a biotech bringing to market a first-in-class allogeneic innate cell therapy, today announces...
Mar 6, 2022
LIfT BioSciences secures its largest financing to date with a further £5m
London, 21st January 2022 – Biotech LIfT BioSciences today announced its largest financing round to date with a further £5m investment...
Jan 21, 2022
LIfT BioSciences & King’s College London embark on an exciting new collaboration
London, 26 March – LIfT BioSciences announced today that they have embarked on a collaboration with King’s College London, under the...
Mar 26, 2021
LIfT BioSciences N-LIfT Cell Therapy Successfully Infiltrates Pancreatic Tumours In-vivo
London, 9 November 2020 – LIfT BioSciences, a biotech company developing a first in class innate cell therapy with the potential to...
Nov 9, 2020
LIfT BioSciences secures a further round of funding for its game-changing innate cell therapy
London, 15th January 2020 – Biotech LIfT BioSciences today announced a further major investment into the company in its mission to...
Jan 15, 2020
LIfT BioSciences signals a new dawn in Cancer Therapy at The Prostate Cancer Foundation Retreat
Alex Blyth, CEO of LIfT BioSciences, delivered the closing presentation for The 25th Prostate Cancer Foundation Retreat in Carlsbad, USA...
Feb 12, 2019
Newsletter.
Stay up-to-date with our progress and latest news.
bottom of page